Company: Dexcom

DXCM

Stock Code:

Enter Stock Code:

This report provides insider trading pattern and statistics for "Dexcom (DXCM)" . Please read important descriptions at the bottom of this report.

Register Free Insider Trade Email Alert for "Dexcom (DXCM)" !



 

Analysis & Screening

Chart Screening Tool

  Transaction Date

  Filing Date

Start Date:

Select Start Date

End Date:

Select End Date

Trading History Screening Tool

Transaction Code:

Ownership:

Share Class:

Trade Price From:

to

Transaction History From February 28th, 2017 To March 29th, 2017 (Max 50 Records Displayed)

Filing Date

Trade Date

 

Insider Name

Event Code

Ownership

Trade Information

Holding % Change

Mar 24/17

Mar 23/17

CxO Sell

DOUBLEDAY RICHARD

EVP, Chief Commercial Officer

S

Indirect ownership

Disposed -3,182 Common Stock at $76.38

-24.99%

Mar 24/17

Mar 23/17

CxO Sell

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

S

Direct ownership

Disposed -3,987 Common Stock at $76.25

-3.25%

Mar 24/17

Mar 22/17

CxO Sell

ROPER JESS

SVP, CFO

S

Indirect ownership

Disposed -2,000 Common Stock at $75.97

-19.14%

Mar 21/17

Mar 17/17

First-Class Insider Sell

SAYER KEVIN R

President & CEO

M

Direct ownership

Disposed -10,000 Non-Qualified Stock Option (right to buy) at $77.82

-42.29%

Mar 21/17

Mar 17/17

First-Class Insider Sell

SAYER KEVIN R

President & CEO

S

Direct ownership

Disposed -10,000 Common Stock at $77.82

-2.83%

Mar 21/17

Mar 17/17

First-Class Insider Buy

SAYER KEVIN R

President & CEO

M

Direct ownership

Acquired 10,000 Common Stock at $8.79

2.91%

Mar 15/17

Mar 14/17

CxO Sell

Leach Jacob Steven

SVP, Research & Development

S

Direct ownership

Disposed -3,050 Common Stock at $77.32

-3.58%

Mar 16/17

Mar 14/17

Company Director Sell

KAHN BARBARA

S

Indirect ownership

Disposed -3,000 Common Stock at $77.36

-12.34%

Mar 14/17

Mar 13/17

CxO Sell

VALDES JORGE A

CTO

S

Indirect ownership

Disposed -14,400 Common Stock at $77.74

-57.97%

Mar 15/17

Mar 13/17

CxO Sell

Leach Jacob Steven

SVP, Research & Development

S

Direct ownership

Disposed -2,732 Common Stock at $77.78

-3.11%

Mar 15/17

Mar 13/17

CxO Sell

Leach Jacob Steven

SVP, Research & Development

S

Direct ownership

Disposed -5,194 Common Stock at $78.07

-5.58%

Mar 14/17

Mar 10/17

CxO Sell

MOY JEFFREY

SVP, Operations

J

Direct ownership

Disposed -11,000 Common Stock at $78.24

-16.06%

Mar 14/17

Mar 10/17

CxO Sell

MOY JEFFREY

SVP, Operations

J

Direct ownership

Disposed -6,667 Common Stock at $78.24

-8.87%

Mar 14/17

Mar 10/17

CxO Sell

MOY JEFFREY

SVP, Operations

J

Direct ownership

Disposed -8,334 Common Stock at $78.24

-9.98%

Mar 14/17

Mar 10/17

CxO Buy

MOY JEFFREY

SVP, Operations

J

Indirect ownership

Acquired 8,334 Common Stock at $78.24

16.48%

Mar 14/17

Mar 10/17

CxO Sell

Balo Andrew K

EVP, Clinical and Regulatory

D

Direct ownership

Disposed -3,208 Common Stock at $77.55

-2.69%

Mar 14/17

Mar 10/17

CxO Sell

Balo Andrew K

EVP, Clinical and Regulatory

D

Direct ownership

Disposed -6,694 Common Stock at $77.55

-5.32%

Mar 14/17

Mar 10/17

CxO Sell

Balo Andrew K

EVP, Clinical and Regulatory

D

Direct ownership

Disposed -3,528 Common Stock at $77.55

-2.73%

Mar 14/17

Mar 10/17

CxO Sell

Balo Andrew K

EVP, Clinical and Regulatory

S

Direct ownership

Disposed -3,200 Common Stock at $77.71

-2.41%

Mar 14/17

Mar 10/17

CxO Sell

ROPER JESS

SVP, CFO

D

Direct ownership

Disposed -1,948 Common Stock at $77.55

-3.64%

Mar 14/17

Mar 10/17

CxO Sell

VALDES JORGE A

CTO

D

Indirect ownership

Disposed -3,964 Common Stock at $77.55

-13.76%

Mar 14/17

Mar 10/17

CxO Sell

VALDES JORGE A

CTO

D

Indirect ownership

Disposed -6,694 Common Stock at $77.55

-18.86%

Mar 14/17

Mar 10/17

CxO Buy

MOY JEFFREY

SVP, Operations

J

Indirect ownership

Acquired 6,667 Common Stock at $78.24

11.32%

Mar 14/17

Mar 10/17

CxO Buy

MOY JEFFREY

SVP, Operations

J

Indirect ownership

Acquired 11,000 Common Stock at $78.24

16.78%

Mar 15/17

Mar 10/17

CxO Sell

Leach Jacob Steven

SVP, Research & Development

M

Direct ownership

Disposed -7,500 Incentive Stock Option (right to buy) at $7.63

-100.00%

Mar 10/17

Mar 10/17

First-Class Insider Sell

GREGG TERRANCE H

Executive Chairman

D

Direct ownership

Disposed -14,512 Common Stock at $77.55

-3.09%

Mar 15/17

Mar 10/17

CxO Buy

Leach Jacob Steven

SVP, Research & Development

M

Direct ownership

Acquired 7,500 Common Stock at $7.63

8.76%

Mar 15/17

Mar 10/17

CxO Sell

Leach Jacob Steven

SVP, Research & Development

D

Direct ownership

Disposed -2,538 Common Stock at $77.55

-2.88%

Mar 15/17

Mar 10/17

CxO Sell

Leach Jacob Steven

SVP, Research & Development

D

Direct ownership

Disposed -5,473 Common Stock at $77.55

-5.84%

Mar 15/17

Mar 10/17

CxO Sell

Leach Jacob Steven

SVP, Research & Development

D

Direct ownership

Disposed -1,950 Common Stock at $77.55

-2.04%

Mar 14/17

Mar 10/17

CxO Sell

ROPER JESS

SVP, CFO

D

Direct ownership

Disposed -5,120 Common Stock at $77.55

-9.92%

Mar 14/17

Mar 10/17

CxO Sell

ROPER JESS

SVP, CFO

D

Direct ownership

Disposed -2,538 Common Stock at $77.55

-4.52%

Mar 14/17

Mar 10/17

CxO Sell

MOY JEFFREY

SVP, Operations

D

Indirect ownership

Disposed -5,813 Common Stock at $77.55

-8.25%

Mar 14/17

Mar 10/17

CxO Sell

MOY JEFFREY

SVP, Operations

D

Indirect ownership

Disposed -2,867 Common Stock at $77.55

-3.91%

Mar 14/17

Mar 10/17

CxO Sell

MOY JEFFREY

SVP, Operations

D

Indirect ownership

Disposed -3,213 Common Stock at $77.55

-4.20%

Mar 14/17

Mar 10/17

CxO Buy

VALDES JORGE A

CTO

J

Indirect ownership

Acquired 12,667 Common Stock at $78.24

55.48%

Mar 14/17

Mar 10/17

CxO Buy

VALDES JORGE A

CTO

J

Indirect ownership

Acquired 7,500 Common Stock at $78.24

48.91%

Mar 14/17

Mar 10/17

CxO Buy

VALDES JORGE A

CTO

J

Indirect ownership

Acquired 11,834 Common Stock at $78.24

338.21%

Mar 10/17

Mar 10/17

CxO Sell

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

D

Direct ownership

Disposed -3,824 Common Stock at $77.55

-2.77%

Mar 10/17

Mar 10/17

CxO Sell

DOUBLEDAY RICHARD

EVP, Chief Commercial Officer

D

Direct ownership

Disposed -3,208 Common Stock at $77.55

-3.18%

Mar 10/17

Mar 10/17

CxO Sell

DOUBLEDAY RICHARD

EVP, Chief Commercial Officer

D

Direct ownership

Disposed -3,527 Common Stock at $77.55

-3.37%

Mar 10/17

Mar 10/17

CxO Sell

DOUBLEDAY RICHARD

EVP, Chief Commercial Officer

D

Direct ownership

Disposed -6,694 Common Stock at $77.55

-6.02%

Mar 10/17

Mar 10/17

CxO Sell

LISTER JOHN

General Manager, EMEA

D

Direct ownership

Disposed -3,537 Common Stock at $77.55

-4.04%

Mar 10/17

Mar 10/17

CxO Sell

LISTER JOHN

General Manager, EMEA

D

Direct ownership

Disposed -6,161 Common Stock at $77.55

-6.57%

Mar 10/17

Mar 10/17

First-Class Insider Sell

GREGG TERRANCE H

Executive Chairman

D

Direct ownership

Disposed -1,661 Common Stock at $77.55

-0.35%

Mar 10/17

Mar 10/17

First-Class Insider Sell

SAYER KEVIN R

President & CEO

D

Direct ownership

Disposed -7,927 Common Stock at $77.55

-2.25%

Mar 10/17

Mar 10/17

CxO Sell

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

D

Direct ownership

Disposed -4,540 Common Stock at $77.55

-3.39%

Mar 10/17

Mar 10/17

CxO Sell

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

D

Direct ownership

Disposed -6,694 Common Stock at $77.55

-5.17%

Mar 14/17

Mar 10/17

CxO Sell

VALDES JORGE A

CTO

J

Direct ownership

Disposed -12,667 Common Stock at $78.24

-23.90%

Mar 14/17

Mar 10/17

CxO Sell

VALDES JORGE A

CTO

J

Direct ownership

Disposed -7,500 Common Stock at $78.24

-12.40%

Company: Dexcom

DXCM

Stock Code:

Chart and trading summary tables represent transactions by company directors, chief executives(CEO, CFO, and senior company officers), corporate substantial shareholders, director's/executive's interest in affiliates of listed corporates, and individual substantial shareholders. Data on this page include all "Dexcom (DXCM)" securities traded or transferred within the specified date range defined in stock screening and analysis panel beside the chart. (Note that, not all corporate insiders will record their trading price or number of shares bought/sold in their filings. The missing data are not included in the trading summary calculation). Different insider symbols in the price chart represent transaction activities on a particular date (Not Stock Trading Price). Additionally, transaction price in chart and trading summary table are adjusted for foreign currency exchange rate on the best efforts. The trading summary in net stock buying or stock selling totals are done on a best efforts basis. All data presented should be treated as estimates as it is based on insider trade filings which are subject to errors if input mistakes are made by a filers. Mouse over on signals to see the transaction details in the transaction info box. The chart is optimized for IE5 or above.

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.